Подписаться
Kamran Aryana
Kamran Aryana
Assistant professor of nuclear medicine
Подтвержден адрес электронной почты в домене mums.ac.ir
Название
Процитировано
Процитировано
Год
Factors influencing the time of sentinel node visualization in breast cancer patients using intradermal injection of the radiotracer
M Aliakbarian, B Memar, A Jangjoo, SR Zakavi, VRD Kakhki, K Aryana, ...
The American journal of surgery 202 (2), 199-202, 2011
642011
Head-to-Head Comparison of Fibroblast Activation Protein Inhibitors (FAPI) Radiotracers versus [18F]F-FDG in Oncology: A Systematic Review
G Treglia, B Muoio, H Roustaei, Z Kiamanesh, K Aryana, R Sadeghi
International Journal of Molecular Sciences 22 (20), 11192, 2021
452021
Treatment efficacy of 153Sm-EDTMP for painful bone metastasis
N Ayati, K Aryana, A Jalilian, T Hoseinnejad, AB Samani, Z Ayati, ...
Asia Oceania Journal of Nuclear Medicine and Biology 1 (1), 27, 2013
392013
99mTc-labeled ubiquicidin scintigraphy A promising method in hip prosthesis infection diagnosis
K Aryana, A Hootkani, R Sadeghi, Y Davoudi, M Naderinasab, M Erfani, ...
Nuklearmedizin 51 (04), 133-139, 2012
39*2012
Botulinum toxin for prevention of delayed gastric emptying after esophagectomy
R Bagheri, SH Fattahi, SZ Haghi, K Aryana, A Aryanniya, S Akhlaghi, ...
Asian Cardiovascular and Thoracic Annals 21 (6), 689-692, 2013
342013
Association of Helicobacter pylori infection with the Lewis and ABO blood groups in dyspeptic patients
K Aryana, MR Keramati, SR Zakavi, MH Sadeghian, H Akbari
Nigerian Medical Journal 54 (3), 196-199, 2013
322013
Diagnostic value of 99mTc-bombesin scintigraphy for differentiation of malignant from benign breast lesions
F Shariati, K Aryana, A Fattahi, MN Forghani, A Azarian, SR Zakavi, ...
Nuclear medicine communications 35 (6), 620-625, 2014
282014
The Iranian Society of Nuclear Medicine practical guideline on radioligand therapy in metastatic castration-resistant prostate cancer using 177Lu-PSMA
H Ahmadzadehfar, K Aryana, E Pirayesh, S Farzanehfar, M Assadi, ...
Iranian Journal of Nuclear Medicine 26 (1), 2, 2018
252018
Could Fibroblast Activation Protein (FAP)‐Specific Radioligands Be Considered as Pan‐Tumor Agents?
H Roustaei, Z Kiamanesh, E Askari, R Sadeghi, K Aryana, G Treglia
Contrast Media & Molecular Imaging 2022 (1), 3948873, 2022
242022
68Ga-FAPI-46 PET/CT in a metastatic castration-resistant prostate cancer patient with low PSMA expression
K Aryana, R Manafi-Farid, H Amini, G Divband, SZ Moghadam
Clinical Nuclear Medicine 47 (11), 972-973, 2022
132022
Diagnostic value of 99mTc-ubiquicidin scintigraphy in differentiation between osteomyelitis and bone tumors
N Ayati, M Norouzi, R Sadeghi, M Erfani, M Gharedaghi, K Aryana
Nuclear Medicine Communications 38 (11), 885-890, 2017
132017
Efficacy, safety and prognostic factors affecting overall survival among metastatic prostate cancer patients undergoing treatment with 177Lu-PSMA-617: a single center study
SZ Moghadam, E Askari, G Divband, S Shakeri, K Aryana
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 41 …, 2022
122022
Fibroblast activation protein inhibitor imaging and therapy in a patient with multiple endocrine neoplasia type 2A syndrome
S Barashki, G Divband, E Askari, H Amini, K Aryana
Clinical Nuclear Medicine 47 (3), e284-e286, 2022
122022
Systemic absorption of Tc-99m-pertechnetate during dacryoscintigraphy: a note of caution
NK Ayati, RG Malekshahi, SR Zakavi, VR Dabbagh Kakhki, K Aryana, ...
Orbit 29 (5), 269-270, 2010
122010
The efficacy of Tc-99m sestamibi for sentinel node mapping in breast carcinomas: comparison with Tc-99m antimony sulphide colloid
R Sadeghi, SR Zakavi, MN Forghani, K Aryana, VRD Kakhki, NK Ayati, ...
Nuclear Medicine Review 13 (1), 1-4, 2010
122010
Favorable response after only one cycle of peptide receptor radionuclide therapy with 177Lu-DOTATATE in a patient with metastatic Merkel cell carcinoma
SZ Moghadam, G Divband, S Shakeri, K Aryana
Clinical Nuclear Medicine 44 (8), 650-652, 2019
112019
Nano liposomes labeled with 99mTc-HMPAO, a novel agent for blood pool imaging
K Sadri, S Momenypoor, VRD Kakhki, R Sadeghi, K Aryana, FJ Daha, ...
Iranian journal of pharmaceutical research: IJPR 14 (4), 981, 2015
112015
Prostate Cancer With Neuroendocrine Differentiation Recurring After Treatment With 177Lu-PSMA: A Chance for: 177: Lu-DOTATATE Therapy?
FN Javan, K Aryana, E Askari
Clinical Nuclear Medicine 46 (9), e480-e482, 2021
102021
Sentinel lymph node biopsy in melanoma patients: An experience with Tc-99m antimony sulfide colloid
BM MEHRABI, MN Forghani, B Memar, A Jangjou, KVR DABAGH, ...
IRANIAN JOURNAL OF NUCLEAR MEDICINE 18 (133), 1-6, 2010
82010
 Application of 99mTc-UBI 29–41 scintigraphy in knee periprosthetic infection diagnosis
Z Kiamanesh, N Ayati, R Alavi, M Gharedaghi, K Aryana
Nuklearmedizin-NuclearMedicine 58 (04), 301-308, 2019
62019
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20